Publicaciones en colaboración con investigadoras/es de Hospital de Cruces (71)

2022

  1. Pearls & Oy-sters: Challenges and Controversies in Wilson Disease

    Neurology, Vol. 99, Núm. 6, pp. 251-255

2018

  1. Sporadic Creutzfeldt–Jakob disease with glial PrPRes nuclear and perinuclear immunoreactivity

    Neuropathology, Vol. 38, Núm. 5, pp. 561-567

2017

  1. Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations

    Current Neurology and Neuroscience Reports, Vol. 17, Núm. 4

  2. Fatal familial insomnia: mitochondrial and protein synthesis machinery decline in the mediodorsal thalamus

    Brain Pathology, Vol. 27, Núm. 1, pp. 95-106

2016

  1. Identification of new molecular alterations in fatal familial insomnia

    Human molecular genetics, Vol. 25, Núm. 12, pp. 2417-2436

  2. Iowa APP mutation-related hereditary cerebral amyloid angiopathy (CAA): A new family from Spain

    Journal of the Neurological Sciences

  3. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson’s disease

    Journal of Neurology, Vol. 263, Núm. 5, pp. 895-905

  4. Manifestaciones neurológicas en la enfermedad de Erdheim-Chester: a propósito de 2 casos

    Neurologia

  5. Sporadic adult-onset leucodystrophy with axonal spheroids and pigmented glia with no mutations in the known targeted genes

    Histopathology, Vol. 68, Núm. 2, pp. 308-312

2015

  1. Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations

    Parkinsonism and Related Disorders, Vol. 21, Núm. 7, pp. 717-722

  2. Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension

    Journal of Human Hypertension, Vol. 29, Núm. 10, pp. 604-609

  3. Coexistence of mixed phenotype Creutzfeldt-Jakob disease, Lewy body disease and argyrophilic grain disease plus histological features of possible Alzheimer's disease: A multi-protein disorder in an autopsy case

    Neuropathology, Vol. 35, Núm. 1, pp. 56-63

  4. Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene

    Parkinsonism and Related Disorders, Vol. 21, Núm. 5, pp. 494-499

  5. Enfermedad de Hirayama: ¿operar o no operar?

    Neurologia

  6. Experience with immunotherapy in 3 patients with cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies

    Neurologia

  7. Neurogenetic Disorders in the Basque Population

    Annals of Human Genetics, Vol. 79, Núm. 1, pp. 57-75

2013

  1. A novel form of human disease

    Prion Biology: Research and Advances (Apple Academic Press), pp. 179-210

  2. Autonomic dysfunction in parkinsonian LRRK2 mutation carriers

    Parkinsonism and Related Disorders, Vol. 19, Núm. 10, pp. 906-909

  3. Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the α synuclein gene

    Parkinsonism and Related Disorders, Vol. 19, Núm. 1, pp. 95-100

  4. Neuropsychiatric symptoms in amnestic mild cognitive impairment: Increased risk and faster progression to dementia

    Current Alzheimer Research, Vol. 10, Núm. 1, pp. 86-94